T1	TimeInfo 3 13	vor 1 Jahr
T2	Condition 23 34	Rejektionen
T3	TimeInfo 35 59	im kurzfristigem Verlauf
T4	Condition 61 70	Banff IIb
T5	Condition 72 81	Banff IIA
T6	Condition 83 91	Banff IB
T7	DiagLab 117 121	NiBi
T8	LabValues 165 168	DSA
T13	LabValues 210 214	Krea
T14	Measure 215 223	steigend
T15	LabValues 225 227	PU
T16	Measure 228 235	niedrig
R1	has_Measure arg1:T13 arg2:T14
R2	has_Measure arg1:T15 arg2:T16
T18	Tx_middle 0 13	TX vor 1 Jahr
T17	Tx_high 186 204	höheres Donoralter
A1	ref_age T17 donor
R3	has_TimeInfo arg1:T2 arg2:T3	
A2	Risk T18 risk_factor
A3	Risk T2 increase_risk_factor
A4	Risk T4 increase_risk_factor
T9	Temporal 0 14	TX vor 1 Jahr,
A5	Temporal_Element T9 past
T10	Temporal 15 155	seitdem Rejektionen im kurzfristigem Verlauf: Banff IIb, Banff IIA, Banff IB plus C4d Nachweis in der NiBi , intensivierte Therapie inkl. PP
A6	Temporal_Element T10 past_present
A7	Risk T5 increase_risk_factor
A8	Risk T6 increase_risk_factor
R4	has_State arg1:T7 arg2:T6	
R5	has_State arg1:T7 arg2:T5	
R6	has_State arg1:T7 arg2:T4	
T11	Medication 124 146	intensivierte Therapie
A9	Risk T11 decrease_risk_factor
T19	Measure 169 184	Klasse I und II
R7	has_Measure arg1:T8 arg2:T19	
A10	Risk T8 increase_risk_factor
A11	Risk T17 risk_factor
T12	Condition 206 208	MM
T20	Measure 208 209	4
R8	has_Measure arg1:T12 arg2:T20	
A12	Risk T12 increase_risk_factor
A13	Risk T13 increase_symptom
A14	Risk T15 decrease_symptom
T21	Temporal 156 209;210 224	Nachweis DSA Klasse I und II, höheres Donoralter, MM4 Krea steigend,
A15	Temporal_Element T21 past_present
T22	Temporal 225 235	PU niedrig
A16	Temporal_Element T22 present
